首页 › 基金 › Neumann Advisory Hong Kong Ltd › SVA
Neumann Advisory Hong Kong Ltd 对 SVA 的持仓历史
Sinovac Biotech Ltd.
Neumann Advisory Hong Kong Ltd 在 Q3 2026 的 13F 申报中披露持有 SVA(Sinovac Biotech Ltd.)315,586 股,市值约 US$2.0M,约占其申报组合的 0.65%,在其申报持仓中市值排名第 4 位。 Neumann Advisory Hong Kong Ltd 最近 13 个申报季度中有 13 个季度披露了 SVA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Neumann Advisory Hong Kong Ltd 对 SVA 的持仓演变
Neumann Advisory Hong Kong Ltd 于 Q3 2023 首次披露 SVA 持仓:315,586 股(约 US$2.0M)。 在 13 次申报中,Neumann Advisory Hong Kong Ltd 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 315,586 股、市值约 US$2.0M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 315.59K | $2.04M | 新进 |
| Q4 2023 | 315.59K | $2.04M | 持有 |
| Q1 2024 | 315.59K | $2.04M | 持有 |
| Q2 2024 | 315.59K | $2.04M | 持有 |
| Q3 2024 | 315.59K | $2.04M | 持有 |
| Q4 2024 | 315.59K | $2.04M | 持有 |
| Q1 2025 | 315.59K | $2.04M | 持有 |
| Q2 2025 | 315.59K | $2.04M | 持有 |
| Q3 2025 | 315.59K | $2.04M | 持有 |
| Q4 2025 | 315.59K | $2.04M | 持有 |
| Q1 2026 | 315.59K | $2.04M | 持有 |
| Q2 2026 | 315.59K | $2.04M | 持有 |
| Q3 2026 | 315.59K | $2.04M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SVA 与 13F 数据
SVA(Sinovac Biotech Ltd.)的行业分类暂缺。我们追踪的基金中还有 8 只申报持有 SVA,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$184.5M), Vivo Capital, LLC (US$38.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SVA 的基金
- ORBIMED ADVISORS LLC 2.72M 股 · $184.47M · Q2 2026
- Vivo Capital, LLC 5.90M 股 · $38.19M · Q2 2026
更多关于 Neumann Advisory Hong Kong Ltd
常见问题
How long has Neumann Advisory Hong Kong Ltd held SVA?
Neumann Advisory Hong Kong Ltd has disclosed SVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Neumann Advisory Hong Kong Ltd's current position in SVA?
As of Q3 2026, Neumann Advisory Hong Kong Ltd holds 315.59K shares of SVA (Sinovac Biotech Ltd.), valued at $2.04M, representing 0.65% of its reported portfolio and ranking #4.
Has Neumann Advisory Hong Kong Ltd been buying or selling SVA?
In the latest 13F filing (Q3 2026), Neumann Advisory Hong Kong Ltd held unchanged its position in SVA.
Which other funds hold SVA?
Other major institutional holders of SVA include ORBIMED ADVISORS LLC, Vivo Capital, LLC, among 8 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.